Mr. Donald McCaffrey reports

RESVERLOGIX CORP. SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT

Holders of common shares of Resverlogix Corp. have approved the special resolution relating to the proposed spinout of RVX Therapeutics Inc. to Zenith Epigenetics Corp. (formerly 1741273 Alberta Ltd.), a newly incorporated company (Newco), pursuant to a plan of arrangement under the Business Corporations Act (Alberta). Upon completion of the arrangement, shareholders of Resverlogix will own one common share of Resverlogix and one common share of Newco for each common share of Resverlogix held immediately prior to the arrangement becoming effective.

The arrangement was approved by approximately 99.89 per cent of the votes cast by shareholders at the special meeting of shareholders held earlier today. Resverlogix will be making an application for the final order of the Court of Queen's Bench of Alberta in respect of the arrangement on May 30, 2013.

At the meeting, shareholders also approved ordinary resolutions approving: (i) a stock option plan for Newco to be effective upon completion of the arrangement; and (ii) a long-term incentive plan for Newco to be effective upon completion of the arrangement.

As previously announced, pursuant to the arrangement, Resverlogix will retain its research and development activities related to the development of compounds for applications with indications involving a therapeutic increase in Apolipoprotein A-1, including the clinical program related to RVX-208. Resverlogix will spin off all other research and development activities related to its epigenetic platform technology to Newco.

The closing of the arrangement remains subject to the satisfaction or waiver of the other conditions specified in the arrangement agreement between Resverlogix, Therapeutics and Newco entered into on April 29, 2013. If the final order is obtained on May 30, 2013, in form and substance satisfactory to Resverlogix and Newco, and all other conditions specified in the arrangement agreement are satisfied or waived, Resverlogix and Newco expect that the closing of the arrangement will occur on June 3, 2013.

We seek Safe Harbor.